ClinicalTrials.gg
Drug

Canagliflozin clinical trials

Also written Invokana and JNJ-28431754.

studies test it
122
open now
12
in phase 3
20
first study started
2005

How each study uses Canagliflozin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Canagliflozin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Mar 2013 · INVOKANA · NDA 204042 (FDA, Drugs@FDA)
European Union
15 Nov 2013 · Invokana · EMEA/H/C/002649 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Canagliflozin
51
Canagliflozin (JNJ-28431754)
12
Canagliflozin 300 mg
11
Canagliflozin 100 mg
9
Canagliflozin, 100 mg
6

Brand

Invokana
21

Development codes

JNJ-28431754
17
TA-7284
1

Studies by the year they started

121 studies that test it; most in 2014 (18); 1 more planned to start later

Studies that test Canagliflozin, by start year
YearStudies
20051
20061
20073
20089
20094
201012
201116
20125
20134
201418
20153
201611
20174
20184
20191
20203
20213
20226
20231
20246
20252
20264

By phase

A phase 1/2 study counts in both.

Phase 1
53
Phase 2
13
Phase 3
20
Phase 4
30
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 80 · Other 42

Janssen Research & Development, LLC (37) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (28) · Tanabe Pharma Corporation (9) · University of Maryland, Baltimore (2) · McGill University Health Centre/Research Institute of the McGill University Health Centre (2) · The University of Texas Health Science Center at San Antonio (2) · Janssen-Cilag International NV (2) · West China Hospital (2)

Often tested with

Tested in the same studies.

Metformin (15) · Sitagliptin (6) · Empagliflozin (5) · Dapagliflozin (5) · Pioglitazone (3) · Extended Release Metformin Hydrochloride (3) · Vildagliptin (2) · Sotagliflozin (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5, 1 in phase 3

Studies that test Canagliflozin, phase 3 first.

Studies

Open first, then newest update. How each study uses Canagliflozin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 122

See all 122 studies that test Canagliflozin →

Given beside what is tested · 5 — Canagliflozin is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Canagliflozin

What changed recently

From the registry's own updates since Oct 21, 2026.

Codes

What other systems call Canagliflozin · ClinicalTrials.gg INT006557

  • MeSH (NLM) D000068896CanagliflozinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 0SAC974Z85CANAGLIFLOZINConfirmed FDA, NLM, Wikidata
  • RxNorm 1373458Confirmed FDA, Wikidata
  • Wikidata Q47495780canagliflozin hemihydrateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C91018CanagliflozinConfirmed FDA, Wikidata

Also registered as canagliflozin anhydrous (UNII 6S49DGR869 · RxNorm 1546031).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.